ACCESS Newswire

    / Micreos Pharmaceuticals AG (“Micreos”), a preclinical-stage biopharmaceutical company, specializing in developing Engineered Endolysin therapies to target harmful pathogens that cause disease aggravation, has entered into a strategic partnership with Northway Biotech (“NBT”), a Contract Development and Manufacturing Organization (CDMO)

    / General Atomics Aeronautical Systems, Inc. (GA-ASI) welcomes the U.S. Air Force’s designation for its Collaborative Combat Aircraft: the new uncrewed jet fighter will be called the YFQ-42A. The announcement on Monday followed an earlier USAF decision in 2024 that